MedPath

Clinical efficacy and safety observation of Bushen Zhuangjin Decoction in the treatment of early and middlestage knee osteoarthritis

Early Phase 1
Conditions
knee osteoarthritis
Registration Number
ITMCTR2024000094
Lead Sponsor
Henan University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1) Patients who meet the diagnostic criteria for KOA (unilateral or bilateral);
2) Patients aged between 50 and 70 years old, both male and female;
3) The X-ray K-L grade of the knee joint belongs to grade II-III;
4) KOA stage belongs to the early and middle stages;
5) Patients with good basic conditions, suitable for drug treatment, and no obvious indications of surgery;
6) The patient had good compliance and signed the informed consent.

Exclusion Criteria

1) Have taken traditional Chinese medicine decoction, proprietary Chinese medicine or other Western medicine with KOA treatment in the past week;
2) Participants in other research projects before enrollment;
3) Patients with knee joint tumor, tuberculosis, rheumatism, rheumatoid arthritis, gouty arthritis and other diseases;
4) Patients who have undergone knee replacement;
5) Pregnant or planning to become pregnant or lactating women;
6) Patients with severe primary diseases of the heart, cerebrovascular and hematopoietic systems, mental diseases, malignant tumors, and liver and kidney dysfunction;
7) Participants in other clinical trials that affect the evaluation of the results of this study.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath